Combine immune checkpoint indoleamine 2,3-dioxygenase 1 knockdown with ferroptosis inducer Erastin/RSL3 accelerates colorectal cancer cell ferroptosis. [PDF]
Li F +5 more
europepmc +1 more source
Through integrated proteomic and metabolomic profiling, Zhao et al. identified three molecular subtypes of high‐grade serous ovarian cancer. The high‐risk subtype exhibits activated arachidonic acid metabolism and cyclooxygenase‐2 overexpression. This metabolic axis promotes M2‐like macrophage infiltration, which contributes to platinum resistance ...
Yuxi Zhao +11 more
wiley +1 more source
Harnessing Cuproptosis for Antitumor Immunity: A Review of Current Evidence and Therapeutic Strategies. [PDF]
Lu I, Zhang J, Chen X, Wang XJ.
europepmc +1 more source
IMM‐H018, a dual IDO1/NE inhibitor, demonstrates potent therapeutic efficacy in sepsis by simultaneously targeting excessive inflammation and immune dysfunction. It prevents both primary and secondary sepsis through anti‐inflammatory, immune‐restoring, and renoprotective mechanisms, reducing organ damage, improving immune homeostasis, preserving kidney
Yi Zhou +11 more
wiley +1 more source
Unlocking the Secrets of Regulated Cell Death in Large B-Cell Lymphoma Beyond Apoptosis: Signaling Pathways and Therapeutic Options. [PDF]
Tkachenko A, Havranek O.
europepmc +1 more source
Ferroptosis and Radiotherapy in Lung Cancer. [PDF]
Patel PC, Galvan EM.
europepmc +1 more source
Ferroptosis in Anaplastic Thyroid Cancer: Molecular Mechanisms, Preclinical Evidence, and Therapeutic Prospects. [PDF]
Lee J, Roh JL.
europepmc +1 more source
The Molecular Signature of Early-Onset Colorectal Cancer Liver Metastases: Distinct Biology and Clinical Challenges. [PDF]
Tsokkou S +9 more
europepmc +1 more source
CTRP6 as a negative regulator of anti-inflammatory M2 macrophage polarization. [PDF]
Senthil Kumar J +4 more
europepmc +1 more source
Ferroptosis and metabolic reprogramming in the immunosuppressive microenvironment of glioblastoma: emerging mechanisms and novel strategies. [PDF]
Han L, Wang Z, Jiang Y, Zhou H, Zhou H.
europepmc +1 more source

